Free Trial
OTCMKTS:AMAR

Amarillo Biosciences (AMAR) Stock Price, News & Analysis

Amarillo Biosciences logo

About Amarillo Biosciences Stock (OTCMKTS:AMAR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6,100 shs
Average Volume
18,253 shs
Market Capitalization
$25.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amarillo Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMAR Stock News Headlines

Amarillo native earns Rising Star award
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
See More Headlines

AMAR Stock Analysis - Frequently Asked Questions

Amarillo Biosciences, Inc. (OTCMKTS:AMAR) issued its quarterly earnings results on Wednesday, November, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter.

Shares of AMAR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amarillo Biosciences investors own include Fulcrum Therapeutics (FULC), Cerecor (CERC), Neos Therapeutics (NEOS), VIVUS (VVUS), AquaBounty Technologies (AQB), Astria Therapeutics (ATXS) and CymaBay Therapeutics (CBAY).

Company Calendar

Last Earnings
11/14/2018
Today
10/20/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:AMAR
CIK
1014763
Fax
N/A
Employees
2
Year Founded
1984

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.45 million
Net Margins
-41,453.98%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-574.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.07

Sales & Book Value

Annual Sales
$20 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.03) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
42,066,000
Free Float
N/A
Market Cap
$25.24 million
Optionable
Not Optionable
Beta
-0.06

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:AMAR) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners